- Report
- May 2025
- 50 Pages
Global
From €2421EUR$2,650USD£2,064GBP
- Report
- May 2025
- 50 Pages
Global
From €2421EUR$2,650USD£2,064GBP
- Report
- May 2023
- 132 Pages
Global
From €868EUR$950USD£740GBP
- Report
- December 2022
- 350 Pages
Global
From €2283EUR$2,499USD£1,947GBP
€3261EUR$3,570USD£2,781GBP
- Report
- July 2024
- 211 Pages
Global
From €1698EUR$1,859USD£1,448GBP
€2425EUR$2,655USD£2,068GBP
- Book
- September 2024
- 352 Pages
Carnitine is a biotechnology product derived from the amino acid lysine. It is used in a variety of applications, including dietary supplements, sports nutrition, and medical treatments. Carnitine is essential for the transport of fatty acids into the mitochondria, where they are used to produce energy. It is also used to treat certain medical conditions, such as heart disease, kidney disease, and diabetes.
The global carnitine market is driven by the increasing demand for dietary supplements and sports nutrition products. The growing awareness of the health benefits of carnitine is also driving the market. Additionally, the increasing prevalence of chronic diseases, such as heart disease and diabetes, is expected to drive the market.
Some of the major companies in the carnitine market include Lonza Group, Glanbia plc, Ajinomoto Co., Inc., and BASF SE. Show Less Read more